Moonoa uses cognitive behavioural therapy for insomnia (CBT-i) and has conducted over 100 clinical studies resulting in 90% of patients reporting better sleep, and more than 80% leaving the sleeping pills for another day.
Moonoa has raised €1.5M across 1 funding round from 8 investors, most recently a Seed round in May 2021. Based in Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-05-27 | Seed | €1.5M |
| Albert Armengol,Albert Serrano,Cabiedes,Eneko Knorr,Jose Marcilla,K Fund+2 more |
| View deal → |
